We are live on ! Find out more
BC

Broadfin Capital Portfolio holdings

AUM $747M
1-Year Est. Return 100.56%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+100.56%
3 Year Est. Return
+297.65%
5 Year Est. Return
+365.91%
10 Year Est. Return
AUM
$511M
AUM Growth
Cap. Flow
+$509M
Cap. Flow %
99.56%
Top 10 Hldgs %
53.04%
Holding
51
New
51
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 73.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
51
CALL
Teva Pharmaceuticals
TEVA
$35.9B
$83K 0.02%
+3,000
New +$117K

Similar funds

Broadfin Capital's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Broadfin Capital, which disclosed 51 positions worth $511M. Its ten largest holdings account for 53% of the portfolio.

Its largest position is Natus Medical Inc: 2,590,992 shares worth $35.4M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets.

  • Broadfin Capital's largest Q2 2013 buy was Natus Medical Inc: 2,590,992 shares worth $35.4M.
  • Broadfin Capital's ten largest holdings make up 53% of its $511M portfolio in Q2 2013.
  • Broadfin Capital disclosed 51 positions in Q2 2013, its first 13F filing on record.

Based on Broadfin Capital's 13F filing for Q2 2013, filed 14 Aug 2013.